Range Low Price High Price Comment
30 days $83.44 $92.16 Wednesday, 27th Mar 2024 BMRN stock ended at $88.61. This is 0.99% more than the trading day before Tuesday, 26th Mar 2024. During the day the stock fluctuated 0.90% from a day low at $87.94 to a day high of $88.74.
90 days $83.44 $99.25
52 weeks $76.02 $100.38

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
2021-02-26 $80.31 $80.46 $75.30 $77.43 3 024 823
2021-02-25 $83.38 $83.95 $81.35 $81.76 1 514 065
2021-02-24 $82.30 $84.52 $82.20 $83.32 1 027 818
2021-02-23 $80.50 $82.55 $79.12 $82.15 1 085 984
2021-02-22 $81.20 $82.33 $80.13 $81.06 952 007
2021-02-19 $83.58 $83.76 $81.46 $81.76 1 018 154
2021-02-18 $85.49 $85.49 $82.83 $83.27 1 152 176
2021-02-17 $84.54 $86.16 $84.24 $85.80 1 059 126
2021-02-16 $87.41 $87.44 $84.14 $84.94 1 421 824
2021-02-12 $86.27 $87.84 $86.21 $87.04 1 017 290
2021-02-11 $85.93 $86.87 $84.93 $86.86 924 947
2021-02-10 $86.28 $86.65 $84.34 $85.45 796 727
2021-02-09 $86.78 $86.82 $84.83 $85.61 776 036
2021-02-08 $86.16 $87.29 $85.15 $86.29 965 204
2021-02-05 $85.44 $85.90 $84.17 $85.22 750 321
2021-02-04 $83.00 $84.93 $83.00 $84.81 920 609
2021-02-03 $84.00 $84.80 $82.82 $82.82 1 282 540
2021-02-02 $84.00 $84.08 $82.64 $83.19 1 435 779
2021-02-01 $84.01 $84.17 $82.31 $83.00 1 046 151
2021-01-29 $82.67 $83.72 $81.31 $82.78 861 378
2021-01-28 $82.91 $84.07 $81.86 $83.15 958 388
2021-01-27 $85.49 $85.97 $82.80 $83.24 1 135 449
2021-01-26 $88.84 $88.91 $85.80 $85.91 1 542 312
2021-01-25 $88.12 $89.13 $87.68 $88.97 950 605
2021-01-22 $85.86 $88.80 $85.52 $87.99 897 281
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT